Financial Performance - The company expects a net loss of between 700 million and 900 million CNY for the fiscal year 2024, compared to a loss of 215.89 million CNY in the same period last year[3]. - The net profit after deducting non-recurring gains and losses is projected to be a loss of between 760 million and 960 million CNY, compared to a loss of 310.83 million CNY in the previous year[3]. - Non-recurring gains and losses are estimated to impact net profit by approximately 60 million CNY during the reporting period[7]. Revenue and Market Conditions - The decrease in revenue is attributed to weakened market expectations, intensified competition, and ongoing business transformation efforts, leading to a reduction in the proportion of engineering project business[5]. - The company has faced increased difficulty in collecting receivables due to declining payment capabilities of some clients and prolonged audit settlement cycles for older projects[5]. - The aging of accounts receivable has increased, prompting the company to provision for credit losses[5]. Asset Management - The company has recognized impairment losses on certain assets and projects based on prudence due to underperformance[6]. Reporting and Forecasting - The financial data presented is preliminary and has not been audited by the accounting firm, with final figures to be disclosed in the 2024 annual report[4][8]. - The company emphasizes the importance of cautious decision-making for investors due to the preliminary nature of the earnings forecast[8]. - The board of directors has provided a statement regarding the earnings forecast for this period[9].
博世科(300422) - 2024 Q4 - 年度业绩预告